Literature DB >> 26409731

Travel-acquired Japanese encephalitis and vaccination considerations.

Androula Pavli1, Helena C Maltezou.   

Abstract

Japanese encephalitis (JE) is a serious arboviral disease caused by a virus of the genus Flavivirus. Japanese encephalitis is the most common vaccine-preventable virus causing encephalitis in Asia, affecting more than 50,000 persons and leading to 15,000 fatalities per year in endemic countries. For most travelers to Asia, the risk of Japanese encephalitis infection is extremely low and depends on destination, duration of travel, season, and activities. This article reviews travel-acquired Japanese encephalitis with a focus on epidemiology and prevention in the light of the newly available options for active immunization against Japanese encephalitis which have become available, and of the increasing popularity of travels to Japanese encephalitis endemic countries.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26409731     DOI: 10.3855/jidc.5108

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  2 in total

1.  Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®).

Authors:  D Amicizia; F Zangrillo; P L Lai; M Iovine; D Panatto
Journal:  J Prev Med Hyg       Date:  2018-03-30

Review 2.  Travel vaccines throughout history.

Authors:  Androula Pavli; Helena C Maltezou
Journal:  Travel Med Infect Dis       Date:  2022-02-12       Impact factor: 6.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.